Clinical Trial Update: NSAID Effects on Clinical and Imaging Breast Biomarkers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating NSAID effects on clinical and imaging breast biomarkers; completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Conditions

Drugs mentioned

• NSAIDs (non-steroidal anti-inflammatory drugs) (NSAIDs)

Snippet

Sponsor: Stony Brook University | Conditions: Inflammation, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-02-10